All In MedTech

FDA Clearance Tracker · P940013-S007

PRECISION ULTRAVIOLET (VASURFILCON A) HYDROPHILIC CONTACT LENS FOR EXTENDED WEAR

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 4, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 4, 2001

Approved

Time to decision

147 days

Received May 10, 2001. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P940013-S007
Device name
PRECISION ULTRAVIOLET (VASURFILCON A) HYDROPHILIC CONTACT LENS FOR EXTENDED WEAR
Applicant location
Fort Worth, TX
Received
May 10, 2001
Decided
Oct 4, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Express GMP Supplement
Original approval
P940013

Device type

Device class
Class II
Regulation
21 CFR 886.5925
Specialty
Ophthalmology

Every decision under product code LPL

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ALTERNATE MANUFACTURING FACILITIES LOCATED AT CIBA VISION CORPORATION, ATLANTA, GEORGIA AND CIBA VISION BATAM, BATAM ISLAND, INDONESIA.

Source documents

Other decisions for Alcon Laboratories, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.